Informações:
Falhas:
Palavras-chave
Primære neoplasmer i sentralnervesystemet ×
- Clinical Trial (106)
- Brain Neoplasms (102)
- Treatment Form (25)
- On-Study Form (12)
- Follow-Up Studies (11)
- Eligibility Determination (9)
- Baseline (6)
- Radiotherapy (5)
- Off-Treatment (5)
- Pathology (5)
- Adverse event (4)
- Registration (4)
- Laboratories (3)
- Leukemia (3)
- Quality of Life (2)
- Radiology (2)
- HIV Infections (2)
- Disease Response (2)
- Death (2)
- Questionnaires (1)
- Salvage Therapy (1)
- Disease Notification (1)
- Child (1)
- Symptom Assessment (1)
- Document Tracking (1)
- Drug trial (1)
- Parkinsons Disease (1)
- Demography (1)
- HIV (1)
- Neoplasms (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
106 Resultados da pesquisa.
Grupos de itens: Header, Anti-cancer therapy, Type of Prior Therapy, Comments, General Validations, CCRR MODULE
Grupos de itens: Header, Adverse event assessment, Comments, CCRR MODULE
Grupos de itens: Header, Miscellaneous Patient Information, PRE-STUDY NEUROSURGERIES, PRE-TREATMENT IMAGING STUDIES, TUMOR LOCATION, PRIMARY DISEASE, Comments, CCRR MODULE
Grupos de itens: Header, Death Assessment, Comments, CCRR MODULE
Grupos de itens: Header, Height / Weight, Peripheral stem cell transplantation, Organ function, Comments, CCRR MODULE
Grupos de itens: RTOG clinical trial administrative data, Summary of Systemic Treatment, Disease Progression, Assessment of Chemotherapy, Footer
Grupos de itens: Header, Eligibility Assessment, CCRR MODULE
Grupos de itens: Header, Patient status assessment, Endocrine Status, PUBERTAL STATUS, Comments, CCRR MODULE
Grupos de itens: Header, Neuropathology, Comments, CCRR MODULE
Grupos de itens: ECOG clinical trial administrative data, Data amendment, Second primary cancer assessment, Footer Module
Grupo de itens: ECOG clinical trial administrative data
Grupos de itens: Header Module, Data amendment, Section I MEASURABLE LESIONS, T2/FLAIR, T1/Contrast, Section II NON-MEASURABLE LESIONS, T2/FLAIR Non-Measurable Lesions, T1/Contrast Non-Measurable Lesions, Section III, Comments